← Browse by Condition
Medical Condition
essential tremor
Total Trials
7
Recruiting Now
7
Trial Phases
Phase 1, EARLY_Phase 1, Phase 1, Phase 2
ClinicalMetric tracks all active clinical trials for essential tremor sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — essential tremor Clinical Trials
How many clinical trials are currently recruiting for essential tremor?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for essential tremor, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for essential tremor?
essential tremor research spans Phase 1 (3 trials), Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a essential tremor clinical trial?
Eligibility criteria for essential tremor trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 3
Phase 2 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT04501133
Recruiting
Sensory-specific Peripheral Stimulation for Tremor Management
Enrollment
180 pts
Location
United States
Sponsor
Shirley Ryan AbilityLab
NCT06331052
Recruiting
3-D Tractography FUS Ablation for Essential Tremor
Enrollment
24 pts
Location
United States
Sponsor
University of North Carolina, ...
NCT07049003 Phase 1
Recruiting
Deep Brain Stimulation of the Deep Cerebellar Nuclei for Refractory Tremor
Enrollment
12 pts
Location
United States
Sponsor
The Cleveland Clinic
NCT00575081
Recruiting
Physiological Brain Atlas Development
Enrollment
5,000 pts
Location
United States
Sponsor
Vanderbilt University Medical ...
NCT07446192
Recruiting
Magnetoencephalography (MEG) Pilot Study
Enrollment
10 pts
Location
United States
Sponsor
University of Florida
NCT07599592 EARLY_Phase 1
Recruiting
Open Label Study for the Use of Low Intensity Focused Ultrasound for Essential Tremor
Enrollment
20 pts
Location
United States
Sponsor
University of California, Los ...
NCT07344194 Phase 1, Phase 2
Recruiting
Dual-Site Transcranial Magnetic Stimulation of the Supplementary Motor Area and Cerebellum for the Treatment of Essential Tremor.
Enrollment
36 pts
Location
Brazil
Sponsor
São Paulo State University
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology